Effect of Nigella sativa oil extract on cardiometabolic risk factors in type 2 diabetes: A randomized, double‐blind , placebo‐controlled clinical trial

2021 ◽  
Author(s):  
Saeid Hadi ◽  
Reza Daryabeygi‐Khotbehsara ◽  
Parvin Mirmiran ◽  
Jenna McVicar ◽  
Vahid Hadi ◽  
...  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Cardiometabolic Risk ◽  
Nigella Sativa ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Nigella Sativa Oil ◽  
Oil Extract

Effectiveness of the piperine-supplemented Curcuma longa L. in metabolic control of patients with type 2 diabetes: a randomised double-blind placebo-controlled clinical trial

2021 ◽  
pp. 1-10
Author(s):  
Joana Furtado de Figueiredo Neta ◽  
Vivian Saraiva Veras ◽  
Danilo Ferreira de Sousa ◽  
Maria da Conceição dos Santos Oliveira Cunha ◽  
Maria Veraci Oliveira Queiroz ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Metabolic Control ◽  
Curcuma Longa ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Effectiveness of Dichrostachys glomerata Spice Phenolics in Reduction of Oxidative Stress Associated with Obesity and Type 2 Diabetes; a Randomized, Double-Blind Placebo-Controlled Clinical Trial

2013 ◽  
Vol 2 (2) ◽  
pp. 1 ◽  
Author(s):  
Dieudonne Kuate ◽  
Anne Pascale Nouemsi Kengne ◽  
William Dakam ◽  
Blanche Cunegonde Omgba Etoundi ◽  
Ghislain Djiokeng Paka ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Phenolic Content ◽  
Antioxidant Activities ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Ascorbate Concentration ◽  
Concomitant Reduction ◽  
Random Groups

This work evaluated the effect of <em>Dichrostachys glomerata </em>on the improvement of antioxidant biomarkers in obesity and type 2 diabetes participants, in an eight-week randomized, double-blind, placebo-controlled design study. The active (400 mg) or placebo formulation were administered twice daily throughout the study period to two normoglycemic and two diabetic obese random groups. Plasma levels of a total of 8 biochemical parameters were taken at the baseline and after 4 and 8 weeks of treatment. No differences in urate variation were observed while the plasma phenolic content as well as the reduced glutathione level, ascorbate concentration, FRAP value and enzymatic antioxidant activities significantly increased with a concomitant reduction of MDA after 8 weeks compared to placebo (P &lt; 0.01). On the contrary to urate and ascorbate, plasma polyphenol content correlated well with FRAP level in both treated groups indicating that phenolics from the spice greatly contributed to the antioxidant activity.

Effect of Nigella sativa oil supplement on risk factors for cardiovascular diseases in patients with type 2 diabetes mellitus

2020 ◽  
Vol 34 (10) ◽  
pp. 2706-2711
Author(s):  
Akram Kooshki ◽  
Tahereh Tofighiyan ◽  
Neda Rastgoo ◽  
Mohammad Hassan Rakhshani ◽  
Mohammad Miri
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cardiovascular Diseases ◽  
Nigella Sativa ◽  
Nigella Sativa Oil
Sign in / Sign up

Export Citation Format

Share Document